EudraVigilance - EVWEB User Manual

← Back to document page

30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency, 2022. Reproduction is authorised provided the source is acknowledged. 14 March 2021 EMA/501718/2018 Data Analytics and Methods Task Force EudraVigilance - EVWEB user Manual Version corr. EudraVigilance - EVWEB user Manual EMA/501718/2018 Page 2/104 Summary of changes: Section Figure 132 and Table updated EudraVigilance - EVWEB user Manual EMA/501718/2018 Page 3/104 Table of Contents Table of Contents ........................................ ........................................ ........ 3 1. Introduction ........................................ ........................................ ............ 5 About this user Manual .

presentation during all phases of the drug regulatory process (i.e. the pre- and post-authorisation phase). These processes include clinical studies, reports of spontaneous adverse reactions, events, regulatory submissions and regulated product …

  Manual, User, Regulatory, Clinical, Eudravigilance, Eudravigilance evweb user manual, Evweb